問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

許銘澤醫師
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2020-05-01 - 2023-02-22

Phase I/II

A Phase 1b/2a, Open-Label Study to Evalute the Safety, Tolerability and Immunogenicity of VTP-300 with or wuthout Nivoulumab in Participants with Chronic Hepatitis B infecttion
  • Condition/Disease

    Chronic Hepatitis B

  • Test Drug

    ChAdOx1-HBV; MVA-HBV; Nivolumab

Participate Sites
6Sites

Not yet recruiting5Sites

Recruiting1Sites